{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:26:34Z","timestamp":1761863194141},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T00:00:00Z","timestamp":1355961600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0052019","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T21:57:21Z","timestamp":1356040641000},"page":"e52019","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Incidence of WHO Stage 3 and 4 Conditions following Initiation of Anti-Retroviral Therapy in Resource Limited Settings"],"prefix":"10.1371","volume":"7","author":[{"given":"Andrea J.","family":"Curtis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine S.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Spelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Greig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian H.","family":"Elliot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Shanks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Du Cros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther C.","family":"Casas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcio Silveria","family":"Da Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel P.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,12,20]]},"reference":[{"key":"ref1","unstructured":"World Health Organisation (2010) Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach: 2010 revision. Geneva."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/COH.0b013e328333850f","article-title":"Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings","volume":"5","author":"SD Lawn","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1097\/QAD.0b013e32801086b0","article-title":"Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi","volume":"20","author":"R Zachariah","year":"2006","journal-title":"AIDS"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/01.aids.0000226959.87471.01","article-title":"Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study","volume":"20","author":"JF Etard","year":"2006","journal-title":"AIDS"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1086\/605500","article-title":"Cause-Specific Mortality and the Contribution of Immune Reconstitution Inflammatory Syndrome in the First 3 Years after Antiretroviral Therapy Initiation in an Urban African Cohort","volume":"49","author":"B Castelnuovo","year":"2009","journal-title":"Clinical Infectious Diseases"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1001\/jama.282.23.2220","article-title":"AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study","volume":"282","author":"B Ledergerber","year":"1999","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/jinf.2001.0810","article-title":"The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic","volume":"42","author":"NJ Ives","year":"2001","journal-title":"J Infect"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/313843","article-title":"Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy","volume":"30","author":"JE Kaplan","year":"2000","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/QAD.0b013e32833a3967","article-title":"AIDS-defining opportunistic illnesses in US patients, 1994\u20132007: a cohort study","volume":"24","author":"K Buchacz","year":"2010","journal-title":"AIDS"},{"key":"ref10","unstructured":"Lynen L (2006) Clinical HIV\/AIDS Care Guidelines for Resource-poor Settings, Second Edition. M\u00e9decins Sans Fronti\u00e8res Operational Centre Brussels. April."},{"key":"ref11","unstructured":"World Health Organisation (2006) Antiretroviral therapy for adults and adolescents in resource-limited settings:towards universal access. Geneva: World Health Organisation."},{"key":"ref12","unstructured":"World Health Organization (2004) Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach. Geneva."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1001\/archinte.165.4.416","article-title":"The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy","volume":"165","author":"A d\u2019Arminio Monforte","year":"2005","journal-title":"Archives of internal medicine"},{"key":"ref14","first-page":"1993","article-title":"The unseen sample in cohort studies: estimation of its size and effect. Multicenter AIDS Cohort Study. Statistics in medicine","volume":"10(12)","author":"DR Hoover","year":"1991"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/QAD.0b013e328327964f","article-title":"Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort","volume":"23","author":"JE Golub","year":"2009","journal-title":"AIDS"},{"key":"ref16","unstructured":"World Health Organisation (2011) Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"S1099","DOI":"10.1093\/infdis\/jir414","article-title":"The tuberculosis and HIV epidemic in South Africa and the KwaZulu-Natal Research Institute for Tuberculosis and HIV","volume":"204","author":"VO Kasprowicz","year":"2011","journal-title":"J Infect Dis"},{"key":"ref18","unstructured":"World Health Organisation (2011) Rapid advice: diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/S0140-6736(10)60057-8","article-title":"Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort","volume":"375","author":"AS Walker","year":"2010","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(04)17225-5","article-title":"Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda","volume":"364","author":"J Mermin","year":"2004","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/QCO.0b013e32832fa214","article-title":"Treatment of cryptococcal meningitis in resource limited settings","volume":"22","author":"DJ Sloan","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"ref22","unstructured":"World Health Organisation (2011) Global tuberculosis control. World Health Organisation."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e826","DOI":"10.1371\/journal.pone.0000826","article-title":"Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995\u20132001","volume":"2","author":"A Miranda","year":"2007","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.qai.0000230521.86964.86","article-title":"Survival rate and risk factors of mortality among HIV\/tuberculosis-coinfected patients with and without antiretroviral therapy","volume":"43","author":"W Manosuthi","year":"2006","journal-title":"Journal of acquired immune deficiency syndromes"},{"key":"ref25","unstructured":"Fielding K, Grant A, Lewis J, Hayes R, Churchyard G (2012) Individual-level effect of isoniazid preventive therapy on risk of TB: the Thibela TB Study. 19th Conference on Retroviruses and Opportunistic Infections Seattle, USA."},{"key":"ref26","unstructured":"UNICEF\/WHO (2006) Pneumonia: The forgotten killer of children."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0140-6736(04)17140-7","article-title":"Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis","volume":"364","author":"M-L Newell","year":"2004","journal-title":"The Lancet"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/00006454-199609000-00012","article-title":"Cryptococcosis in human immunodeficiency virus-infected children","volume":"15","author":"CE Gonzalez","year":"1996","journal-title":"The Pediatric infectious disease journal"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/515130","article-title":"Cryptococcosis in children with AIDS","volume":"28","author":"J Abadi","year":"1999","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0052019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T20:18:47Z","timestamp":1540239527000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0052019"}},"subtitle":[],"editor":[{"given":"Sten H.","family":"Vermund","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,20]]},"references-count":29,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0052019","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,20]]}}}